Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China
A full evaluation of health conditions is necessary for the effective implementation of public health interventions. However, terms to address the intermediate state between health and disease are lacking, leading the public to overlook this state and thus increasing the risks of developing disease.
A cross-sectional health survey of 1,473 randomly recruited Chinese Han adults of both sexes living in the central region of China. The criteria for diagnosis of subhealth was defined as the presence of ≥ 1 of the following abnormalities: body mass index ≥ 25 kg/m2 or waist circumference ≥ 102 cm in men and 88 cm in women; systolic pressure 120–139 mmHg and/or diastolic pressure 80–89 mmHg; serum triglyceride level ≥ 150 mg/dL and/or total cholesterol level ≥ 200 mg/dL and/or high-density lipoprotein cholesterol level < 40 mg/dL in men and 50 mg/dL in women; serum glucose level 110–125 mg/dL; estimated glomerular filtration rate 60–89 ml/min/1.73 m2; levels of liver enzymes in liver function tests between 41–59 U/L, or with fatty liver disease but < 33% of affected hepatocytes; levels of oxidative stress biomarkers beyond the reference range of 95%; or problems with both sleep quality and psychological state.
The prevalences of subhealth and disease in the central region of China were 36.6% and 43.1%, respectively. The prevalence of disease increased from 26.3% in participants aged 20–39 years, to 47.6% and 78.9% for participants aged 40–59 years and those aged 60 years or older, respectively. Compared with participants aged 20–39, the prevalences of health and subhealth in participants aged 60 years or older decreased by 86.7% and 60.3%, respectively. The prevalence of subhealth was increased in association with increases in lifestyle risk scores, while the prevalences of both health and disease were reduced.
The prevalences of subhealth and disease are high in central China. Subhealth is associated with high lifestyle risk scores. Both the health care sector and the public should pay more attention to subhealth. Lifestyle modifications and/or psychological interventions are needed to ameliorate these conditions.
- Alberti KG, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet 2005,366(9491):1059–1062. CrossRef
- Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998,15(7):539–553. CrossRef
- Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart A, National Heart L, Blood I: Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation 2004,109(3):433–438. CrossRef
- Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM: Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the adult treatment panel III and the international diabetes federation in united states american and european populations. Am J Cardiol 2007,99(4):541–548. CrossRef
- Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS: Heart disease and stroke statistics–2013 update: a report from the American heart association. Circulation 2013,127(1):e6-e245. CrossRef
- Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006,23(5):469–480. CrossRef
- Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E: Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002,28(5):364–376.
- Expert Panel on Detection E, Treatment of High Blood Cholesterol in A: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001,285(19):2486–2497. CrossRef
- Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM: American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003,9(3):237–252.
- Third Report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002,106(25):3143–3421.
- Kahn R: Metabolic syndrome–what is the clinical usefulness? Lancet 2008,371(9628):1892–1893. CrossRef
- Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D: The metabolic syndrome: time for a critical appraisal: joint statement from the american diabetes association and the european association for the study of diabetes. Diabetes Care 2005,28(9):2289–2304. CrossRef
- Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW: Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008,371(9628):1927–1935. CrossRef
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009,120(16):1640–1645. CrossRef
- Li G, He H: Hormesis, allostatic buffering capacity and physiological mechanism of physical activity: a new theoretic framework. Med Hypotheses 2009,72(5):527–532. CrossRef
- McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007,87(3):873–904. CrossRef
- McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 1998,338(3):171–179. CrossRef
- Hampton T: Mitochondrial defects may play role in the metabolic syndrome. JAMA 2004,292(23):2823–2824. CrossRef
- Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr: Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008,299(19):2287–2293. CrossRef
- Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev 1998,78(2):547–581.
- Yin DZ, Chen KJ: The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Exp Gerontol 2005,40(6):455–465. CrossRef
- Turgeon ML: Principles of blood collection. In Clinical hematology: theory and procedures. 4th edition. Edited by: Turgeon ML. Philadelphia: Lippincott Williams & Wilkins; 2004:18–40.
- WHO-Expert-Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004,363(9403):157–163. CrossRef
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003,289(19):2560–2572. CrossRef
- Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and lifestyle study (AusDiab). Circulation 2007,116(2):151–157. CrossRef
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009,150(9):604–612. CrossRef
- National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002,39(2 Suppl 1):S1–266.
- Finney H, Newman DJ, Price CP: Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000,37(Pt 1):49–59. CrossRef
- Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002,346(16):1221–1231. CrossRef
- Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2007,45(2):507–539. CrossRef
- Siest G, Schiele F, Galteau M-M, Panek E, Steinmetz J, Fagnani F, Gueguen R: Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 1975,21(8):1077–1087.
- Li G, He H, Yan H, Zhao Q, Yin D: Does carbonyl stress cause increased blood viscosity during storage? Clin Hemorheol Microcirc 2010,44(2):145–154.
- Grubbs F: Procedures for detecting outlying observations in samples. Technometrics 1969,11(1):1–21. CrossRef
- Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R: Treating the metabolic syndrome. Expert Rev Cardiovasc Ther 2007,5(3):491–506. CrossRef
- Rector RS, Warner SO, Liu Y, Hinton PS, Sun GY, Cox RH, Stump CS, Laughlin MH, Dellsperger KC, Thomas TR: Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab 2007,293(2):E500–506. CrossRef
- Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 2006,100(5):1657–1665. CrossRef
- Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J: Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003,289(5):579–588. CrossRef
- Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB: The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. New Engl J Med 1993,328(8):538–545. CrossRef
- Kottke TE, Battista RN, DeFriese GH, Brekke ML: Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988,259(19):2883–2889. CrossRef
- Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001,345(11):790–797. CrossRef
- Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004,292(12):1440–1446. CrossRef
- Church TS, Earnest CP, Skinner JS, Blair SN: Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 2007,297(19):2081–2091. CrossRef
- Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002,287(3):356–359. CrossRef
- Roberts LJ, Morrow JD: Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Free Radical Biol Med 2000,28(4):505–513. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/13/446/prepub
- Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Public Health
- Online Date
- May 2013
- Online ISSN
- BioMed Central
- Additional Links
- Oxidative stress
- Thiobarbituric acid-reactive substances (TBARS)
- Industry Sectors
- Author Affiliations
- 1. The Key Laboratory of Protein Chemistry and Developmental Biology of Ministry of Education, College of Life Sciences, Hunan Normal University, Changsha, Hunan, 410081, P. R. China
- 3. The Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research of Ministry of Education, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, Hunan, 410081, P. R. China
- 4. The Fourth Hospital of Changsha, Affiliated Hospital of Hunan Normal University, Changsha, Hunan, 410081, P.R. China
- 2. Qingyuan City People’s Hospital of Jinan University, Qingyuan, Guangdong, 511518, P. R. China